Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer
Authors:
Open Access
- 21 July 2016
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (35) , 57452-57463
Abstract
Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancerKeywords
This publication has 96 references indexed in Scilit:
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignanciesProceedings of the National Academy of Sciences, 2011
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesNature Biotechnology, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiationProceedings of the National Academy of Sciences, 2007
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- The functions of animal microRNAsNature, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- The language of covalent histone modificationsNature, 2000